openPR Logo
Press release

Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach New Heights

08-29-2018 10:33 AM CET | Health & Medicine

Press release from: Precision Business Insights

Uveitis Treatment Market

Uveitis Treatment Market

Uveitis Treatment Market
Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.



Uveitis is swelling of the middle layer of the eye, which is called the uvea. It may occur from both infectious and non-infectious causes. It is a group of inflammatory diseases affecting eyes and can cause loss of vision. Causes of uveitis include infections such as brucellosis, leptospirosis, syphilis, tuberculosis, autoimmune diseases such as sarcoidosis, Crohn’s disease, multiple sclerosis, arthritis, ankylosing spondylitis, and psoriatic arthritis. In addition, uveitis is also caused by drugs such as Rifabutin and moxifloxacin.

The growth of uveitis drugs market is due to rise in prevalence and complications related to uveitis. In addition, increase in prevalence rates, market players betting heavily on R & D to develop new drugs, an introduction of biologics into the market, fast approval of the drugs are fueling the market growth of global uveitis treatment market. However, few factors are restraining the growth of the market such as side effects of the drugs, eye irritation and lack of awareness about eye disorders in undeveloped regions, lack of sufficient healthcare infrastructure is hindering the non-infectious uveitis treatment market.

The global uveitis treatment market is categorized as-

Drug class
Corticosteroids
Immunosuppressant
Monoclonal antibodies
Antibiotics
Antivirals
Antifungal
Analgesics
Disease type
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
Type of cause
Infectious Uveitis
Non-Infectious Uveitis
End-users
Hospital Pharmacies, retail pharmacies and others

And lastly on the basis of geographical regions global uveitis treatment market segmented into following regions-North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is leading in global uveitis treatment market due to various factors such as early approval of drugs compared to other regions, increased R & D investments by market players, and high prevalence of the uveitis is contributing growth of the market. In Europe region due to increased prevalence of diseases such as HIV, multiple sclerosis that are underlying causes of uveitis conditions. Japan, China, and India are expected to play important role in the revenue growth of the Asia-Pacific uveitis treatment market due to rapidly developing healthcare infrastructure, increased R & D expenditure and growing awareness about the eye-related diseases. However, manufacturing of eye preparations required aseptic conditions and the manufacturing plant should be GMP certified. Hence the cost related to these preparations is very high that has the direct implication on a cost of the drugs.

Some of the key players in uveitis drugs market include AbbVie Inc. (U.S.), Eyegate Pharmaceuticals Inc. (US), Valeant Pharmaceuticals (Bausch + Lomb) (Canada), Novartis AG (Switzerland), Alimera Sciences Inc. (U.S.) and Santen Pharmaceutical Co. Ltd (Japan) to name a few. In 2016, USFDA approved AbbVie’s HUMIRA for the treatment of non-infectious intermediate, posterior and Panuveitis.

Market players are developing novel molecules that can treat uveitis conditions in order to enhance their sales revenue. Companies are focusing on the development of the various drugs in the treatment of the Uveitis. For instance, Aurinia Pharmaceuticals Inc. developing Luvenia, a calcineurin inhibitor for the treatment of noninfectious Uveitis. Considering the above-mentioned factors non-infectious uveitis treatment market is expected to grow at the significant rate.

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach New Heights here

News-ID: 1207384 • Views: 361

More Releases from Precision Business Insights

Clinical Trials Market Share, Trends, Competitor Analysis and Forecast to 2019-2 …
Analyst Speak: “The Global Clinical Trials Market is expected to reach US$ 69.1 Bn by 2025 due to growing occurrences of life threatening diseases and technological advancements in the field of drug discovery” The global clinical trials market is expected to reach US$ 69.1 Bn by 2025. Clinical trials are experiments or observations done in clinical research to generate data on safety and efficacy. Clinical trials are done on vaccines, drugs,
Diabetes Care Devices Market is Expected to Reach US$ 24,368.4 Mn by 2025
Analyst Speak: “The Diabetes Care Devices Market is increasing at significant CAGR over the forecast period 2019-2025 and expected to reach US$ 24,368.4 Mn by 2025, due to rise in prevalence of diabetes in various countries around the world”. Precision Business Insights (PBI) in its report titled “Diabetes Care Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period
Carbon Fiber Prepreg Market Opportunities, Size, Share, Key Players, and Regiona …
The Global Carbon Fiber Prepreg Market poised to reach US$ XX Mn by 2025 with a significant CAGR over seven years forecast period 2019-2025 owing to the increasing demand from various industries. Precision Business Insights (PBI) in its report titled “Global Carbon Fiber Prepreg Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025.
Global Insulation Coatings Market Growth, Trends, Analysis, Segmentation, Foreca …
Precision Business Insights (PBI) in its report titled “Global Insulation Coating Material Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Global Insulation Coating Material Market

All 5 Releases


More Releases for Uveitis

Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market to Perceive Substantial Growth by 2024
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Market 2018 Global Analysis, Opportunities and Forecast to 2026
Summary Uveitis is an inflammatory condition of the eye affecting mainly the uvea. It encompasses a heterogeneous collection of disorders characterized by ocular inflammation. Currently, there is only a limited number of approved drugs for the treatment of uveitis. Based on the diverse nature of uveitis , there is a high unmet need for varied therapy approaches. Significant efforts are being made to develop new treatments for uveitis, as current pharmacologic
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Global Uveitis Treatment Industry : Market Development, Analysis and Overview 20 …
Researchmoz added Most up-to-date research on "Global Market Study on Uveitis Treatment: Europe Market Projected to Represent Market Attractiveness Index of 1.3" to its huge collection of research reports. Persistence Market Research presents a comprehensive study of the global uveitis treatment market in a new publication titled Uveitis Treatment Market: Global Industry Analysis and Forecast, 20162024. The report forecasts the performance of the global uveitis treatment market across different geographical locations and
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and